Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers.
The Environmental Protection Agency said it has revised a key rule relating to the nation's waters that would weaken efforts to protect acres of wetlands.